Skip to main content

Peer Review reports

From: Sacubitril/valsartan inhibits the proliferation of vascular smooth muscle cells through notch signaling and ERK1/2 pathway

Original Submission
9 Oct 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
4 Nov 2023 Reviewed Reviewer Report
23 Nov 2023 Reviewed Reviewer Report
10 Dec 2023 Author responded Author comments - Yonghong Li
Resubmission - Version 4
10 Dec 2023 Submitted Manuscript version 4
14 Dec 2023 Author responded Author comments - Yonghong Li
Resubmission - Version 5
14 Dec 2023 Submitted Manuscript version 5
30 Dec 2023 Author responded Author comments - Yonghong Li
Resubmission - Version 6
30 Dec 2023 Submitted Manuscript version 6
2 Jan 2024 Author responded Author comments - Yonghong Li
Resubmission - Version 7
2 Jan 2024 Submitted Manuscript version 7
7 Jan 2024 Reviewed Reviewer Report
24 Jan 2024 Reviewed Reviewer Report
29 Jan 2024 Author responded Author comments - Yonghong Li
Resubmission - Version 8
29 Jan 2024 Submitted Manuscript version 8
29 Jan 2024 Author responded Author comments - Yonghong Li
Resubmission - Version 9
29 Jan 2024 Submitted Manuscript version 9
Publishing
3 Feb 2024 Editorially accepted
14 Feb 2024 Article published 10.1186/s12872-024-03764-8

You can find further information about peer review here.

Back to article page